{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-21-007695","form_type":"8-K","ticker":"PLSH","cik":"0001552189","company_name":"PANACEA LIFE SCIENCES HOLDINGS, INC.","filed_at":"2021-07-07T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.541567+00:00","generated_at":"2026-06-30T06:55:34.942546+00:00","sec_items":["1.01","3.02","5.02","5.03","7.01","9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.95,"calibrated_materiality_score":0.95,"confidence":"high","headline":"Exactus acquires Panacea Life Sciences; Leslie Buttorff becomes CEO","bullets":["Exactus issues 473.6M common shares + preferred stock to acquire Panacea; Buttorff owns ~61% fully diluted.","Leslie Buttorff named CEO/CFO with $380K salary plus $2.2M in shares upon NASDAQ listing.","22nd Century Group (XXII) receives 11.6% stake in combined company after exchanging Panacea preferred.","Board reduced to two directors; future additions include XXII CEO Jim Mish and Dr. Janice Nerger.","Reverse stock split 1-for-28 approved; company to rename as Panacea Life Sciences Holdings, Inc."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-21-007695","json":"https://secwatch.observer/filing/0001654954-21-007695.json","markdown":"https://secwatch.observer/filing/0001654954-21-007695.md","text":"https://secwatch.observer/filing/0001654954-21-007695.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1552189/000165495421007695/0001654954-21-007695-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1552189/000165495421007695/exdi8k_june302021.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T06:55:34.942546+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2637bad709","claim":"John Price resigned as director at PANACEA LIFE SCIENCES HOLDINGS, INC..","evidence_excerpt":"John Price, a director (who had not held any officer positions with the Company), previously resigned from as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1552189/000165495421007695/0001654954-21-007695-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"2a77233d89","claim":"Leslie Buttorff was appointed as director at PANACEA LIFE SCIENCES HOLDINGS, INC..","evidence_excerpt":"Leslie Buttorff was appointed director.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1552189/000165495421007695/0001654954-21-007695-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"director"}],"fact_type":"executive_change"},{"claim_id":"650855cbe3","claim":"Mr. Wert resigned as Executive Chairman at PANACEA LIFE SCIENCES HOLDINGS, INC..","evidence_excerpt":"Mr. Wert previously was Executive Chairman but resigned from that role.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1552189/000165495421007695/0001654954-21-007695-index.htm","confidence":0.85,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"},{"claim_id":"9eca03e71e","claim":"Julian Pittam resigned as director at PANACEA LIFE SCIENCES HOLDINGS, INC..","evidence_excerpt":"On June 30, 2021, Julian Pittam resigned as director of the Company","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1552189/000165495421007695/0001654954-21-007695-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}